CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Isoleucine

异亮氨酸 杂质对照品Isoleucine Impurities

EP50 个杂质条目50 impurity entries

本页汇总 异亮氨酸 的 50 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 50 impurity reference standards of Isoleucine with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 异亮氨酸(Isoleucine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsDevelopment and validation of liquid chromatography tandem mass spectrometry method quantitative determination of polymyxin B1, polymyxin B2, polymyxin B3 and isoleucine-polymyxin B1 in human plasma and its application in clinical studies
    Journal of pharmaceutical and biomedical analysis · 2017 · Hee KH et al.  ·  PMID 28343078  ·  DOI
  2. 分析方法Analytical MethodsSeparation and Identification of Isoleucine Enantiomers and Diastereomers Using an Original Chiral Resolution Labeling Reagent
    Chemical & pharmaceutical bulletin · 2023 · Ozaki M et al.  ·  PMID 37612063  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisEngineering of isoleucine dioxygenase for efficient multi-enzymatic cascade synthesis of (2S, 3R, 4S)-4-hydroxyisoleucine
    Bioorganic chemistry · 2025 · Xu X et al.  ·  PMID 41202682  ·  DOI
  • 合成方法SynthesisSynthesis of β-Alanine From Isoleucine and Propionate Catabolism via Aminotransferases
    Plant direct · 2024 · Goldfarb MH et al.  ·  PMID 39703930  ·  DOI
  • 合成方法SynthesisSynthesis of a (13)C-methylene-labeled isoleucine precursor as a useful tool for studying protein side-chain interactions and dynamics
    Journal of biomolecular NMR · 2024 · Höfurthner T et al.  ·  PMID 37816933  ·  DOI

异亮氨酸 —— 原料药与杂质对照品Isoleucine — drug substance & impurities

共 50 个条目(含原料药本体)50 items incl. the drug substance
Isoleucine Impurity 1 (Isoleucine EP Impurity A) (Valine) structure
EPA
异亮氨酸杂质1 (异亮氨酸EP杂质 A)(缬氨酸)Isoleucine Impurity 1 (Isoleucine EP Impurity A) (Valine)
Isoleucine Impurity 1 (Isoleucine EP Impurity A) (Valine)
CAS No.72-18-4
Chemical FormulaC5H11NO2
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 3 (Isoleucine EP Impurity C) (Leucine) structure
EPC
异亮氨酸杂质3 (异亮氨酸EP杂质C) (亮氨酸)Isoleucine Impurity 3 (Isoleucine EP Impurity C) (Leucine)
Isoleucine Impurity 3 (Isoleucine EP Impurity C) (Leucine)
CAS No.61-90-5
Chemical FormulaC6H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 4 (Isoleucine EP Impurity D) (Methionine) structure
EPD
异亮氨酸杂质4 (异亮氨酸EP杂质D)(蛋氨酸)Isoleucine Impurity 4 (Isoleucine EP Impurity D) (Methionine)
Isoleucine Impurity 4 (Isoleucine EP Impurity D) (Methionine)
CAS No.63-68-3
Chemical FormulaC5H11NO2S
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 3-d3 (Isoleucine EP Impurity C-d3) (Leucine-d3) structure
EPC-D3
异亮氨酸杂质3-d3 (异亮氨酸EP杂质C-d3) (亮氨酸-d3)Isoleucine Impurity 3-d3 (Isoleucine EP Impurity C-d3) (Leucine-d3)
Isoleucine Impurity 3-d3 (Isoleucine EP Impurity C-d3) (Leucine-d3)
CAS No.87828-86-2
Chemical FormulaC6H10D3NO2
Purity>95%询价On request
Isoleucine Impurity 3-13C (Isoleucine EP Impurity C-13C) (Leucine-13C) structure
EPC-13C
异亮氨酸杂质3-13C (异亮氨酸EP杂质C-13C) (亮氨酸-13C)Isoleucine Impurity 3-13C (Isoleucine EP Impurity C-13C) (Leucine-13C)
Isoleucine Impurity 3-13C (Isoleucine EP Impurity C-13C) (Leucine-13C)
CAS No.74292-94-7
Chemical FormulaC513CH13NO2
Purity>95%询价On request
10mg25mg50mg100mg
L-Isoleucine-13C6,15N1,d10 structure
—
L-异亮氨酸-13C6,15N1,d10L-Isoleucine-13C6,15N1,d10
L-Isoleucine-13C6,15N1,d10
CAS No.2483829-34-9
Chemical Formula13C6H3D1015NO2
Purity>95%询价On request
10mg25mg50mg100mg
L-Isoleucine-15N1 structure
—
L-异亮氨酸-15N1L-Isoleucine-15N1
L-Isoleucine-15N1
CAS No.59935-30-7
Chemical FormulaC6H1315NO2
Purity>95%询价On request
10mg25mg50mg100mg
L-Isoleucine structure
—
L-异亮氨酸L-Isoleucine
L-Isoleucine
CAS No.73-32-5
Chemical FormulaC6H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
L-Isoleucine-13C1 structure
—
L-异亮氨酸-13C1L-Isoleucine-13C1
L-Isoleucine-13C1
CAS No.81202-02-0
Chemical FormulaC513CH13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 5 structure
5
异亮氨酸杂质5Isoleucine Impurity 5
Isoleucine Impurity 5
CAS No.7517-19-3
Chemical FormulaC7H15NO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 6 structure
6
异亮氨酸杂质6Isoleucine Impurity 6
Isoleucine Impurity 6
CAS No.5845-53-4
Chemical FormulaC7H15NO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 7 structure
7
异亮氨酸杂质7Isoleucine Impurity 7
Isoleucine Impurity 7
CAS No.327-56-0
Chemical FormulaC6H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 8 (D-Isoleucine) structure
8
异亮氨酸杂质8 ( D-异亮氨酸)Isoleucine Impurity 8 (D-Isoleucine)
Isoleucine Impurity 8 (D-Isoleucine)
CAS No.319-78-8
Chemical FormulaC6H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 9 structure
9
异亮氨酸杂质9Isoleucine Impurity 9
Isoleucine Impurity 9
CAS No.616-06-8
Chemical FormulaC6H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 10 Calcium Salt structure
10
异亮氨酸杂质10 钙盐Isoleucine Impurity 10 Calcium Salt
Isoleucine Impurity 10 Calcium Salt
CAS No.51828-95-6
Chemical Formula2(C6H9O3-)·Ca2+
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 10 Monomer structure
10
异亮氨酸杂质10 单体Isoleucine Impurity 10 Monomer
Isoleucine Impurity 10 Monomer
CAS No.816-66-0
Chemical FormulaC6H10O3
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 11 structure
11
异亮氨酸杂质11Isoleucine Impurity 11
Isoleucine Impurity 11
CAS No.328-38-1
Chemical FormulaC6H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 12 structure
12
异亮氨酸杂质12Isoleucine Impurity 12
Isoleucine Impurity 12
CAS No.632-20-2
Chemical FormulaC4H9NO3
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 13 structure
13
异亮氨酸杂质13Isoleucine Impurity 13
Isoleucine Impurity 13
CAS No.351-50-8
Chemical FormulaC6H9N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 14 structure
14
异亮氨酸杂质14Isoleucine Impurity 14
Isoleucine Impurity 14
CAS No.348-67-4
Chemical FormulaC5H11NO2S
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 15 structure
15
异亮氨酸杂质15Isoleucine Impurity 15
Isoleucine Impurity 15
CAS No.3077-46-1
Chemical FormulaC8H15NO3
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 16 structure
16
异亮氨酸杂质16Isoleucine Impurity 16
Isoleucine Impurity 16
CAS No.443-79-8
Chemical FormulaC6H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 17 structure
17
异亮氨酸杂质17Isoleucine Impurity 17
Isoleucine Impurity 17
CAS No.328-39-2
Chemical FormulaC6H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 18 structure
18
异亮氨酸杂质18Isoleucine Impurity 18
Isoleucine Impurity 18
CAS No.1114-81-4
Chemical FormulaC4H10NO6P
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 19 structure
19
异亮氨酸杂质19Isoleucine Impurity 19
Isoleucine Impurity 19
CAS No.32723-76-5
Chemical FormulaC6H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 20 structure
20
异亮氨酸杂质20Isoleucine Impurity 20
Isoleucine Impurity 20
CAS No.62965-57-5
Chemical FormulaC6H14N2O
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 21 Hydrochloride structure
21
异亮氨酸杂质21 盐酸盐Isoleucine Impurity 21 Hydrochloride
Isoleucine Impurity 21 Hydrochloride
CAS No.214402-71-8
Chemical FormulaC5H11NO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 21 structure
21
异亮氨酸杂质21Isoleucine Impurity 21
Isoleucine Impurity 21
CAS No.5937-83-7
Chemical FormulaC5H11NO2
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 22 structure
22
异亮氨酸杂质22Isoleucine Impurity 22
Isoleucine Impurity 22
CAS No.952400-12-3
Chemical FormulaC15H28N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 23 structure
23
异亮氨酸杂质23Isoleucine Impurity 23
Isoleucine Impurity 23
CAS No.1460-34-0
Chemical FormulaC6H10O3
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 23 Calcium Salt (D,L-α-Ketoisoleucine Calcium) structure
23
异亮氨酸杂质23 钙盐 (消旋酮异亮氨酸钙)Isoleucine Impurity 23 Calcium Salt (D,L-α-Ketoisoleucine Calcium)
Isoleucine Impurity 23 Calcium Salt (D,L-α-Ketoisoleucine Calcium)
CAS No.66872-75-1
Chemical Formula2(C6H9O3-)·Ca2+
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 24 (N-Nitroso Isoleucine Impurity 4) structure
24
异亮氨酸杂质24 (N-亚硝基异亮氨酸杂质4)Isoleucine Impurity 24 (N-Nitroso Isoleucine Impurity 4)
Isoleucine Impurity 24 (N-Nitroso Isoleucine Impurity 4)
CAS No.1026878-86-3
Chemical FormulaC5H10N2O3S
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 25 structure
25
异亮氨酸杂质25Isoleucine Impurity 25
Isoleucine Impurity 25
CAS No.2460646-17-5
Chemical FormulaC8H15NO3
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 26 structure
26
异亮氨酸杂质26Isoleucine Impurity 26
Isoleucine Impurity 26
CAS No.327-57-1
Chemical FormulaC6H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 27 structure
27
异亮氨酸杂质27Isoleucine Impurity 27
Isoleucine Impurity 27
CAS No.1821-02-9
Chemical FormulaC5H8O3
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 28 structure
28
异亮氨酸杂质28Isoleucine Impurity 28
Isoleucine Impurity 28
CAS No.167223-42-9
Chemical FormulaC7H15NO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 29 structure
29
异亮氨酸杂质29Isoleucine Impurity 29
Isoleucine Impurity 29
CAS No.60667-85-8
Chemical FormulaC7H15NO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 30 structure
30
异亮氨酸杂质30Isoleucine Impurity 30
Isoleucine Impurity 30
CAS No.3392-09-4
Chemical FormulaC15H24N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 31 structure
31
异亮氨酸杂质31Isoleucine Impurity 31
Isoleucine Impurity 31
CAS No.60111-76-4
Chemical FormulaC15H24N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 32 structure
32
异亮氨酸杂质32Isoleucine Impurity 32
Isoleucine Impurity 32
CAS No.1629959-57-4
Chemical FormulaC9H12O5
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 33 structure
33
异亮氨酸杂质33Isoleucine Impurity 33
Isoleucine Impurity 33
CAS No.210769-82-7
Chemical FormulaC9H17NO4
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 34 structure
34
异亮氨酸杂质34Isoleucine Impurity 34
Isoleucine Impurity 34
CAS No.210769-85-0
Chemical FormulaC9H17NO4
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 35 structure
35
异亮氨酸杂质35Isoleucine Impurity 35
Isoleucine Impurity 35
CAS No.76542-83-1
Chemical FormulaC25H26N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 40 structure
40
异亮氨酸杂质40Isoleucine Impurity 40
Isoleucine Impurity 40
CAS No.1756-18-9
Chemical FormulaC5H10O4
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 41 structure
41
异亮氨酸杂质41Isoleucine Impurity 41
Isoleucine Impurity 41
CAS No.104092-72-0
Chemical FormulaC5H8O3
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 44 structure
44
异亮氨酸杂质44Isoleucine Impurity 44
Isoleucine Impurity 44
CAS No.781658-23-9
Chemical FormulaC6H13NO3
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 45 structure
45
异亮氨酸杂质45Isoleucine Impurity 45
Isoleucine Impurity 45
CAS No.13748-90-8
Chemical FormulaC6H12O3
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 46 structure
46
异亮氨酸杂质46Isoleucine Impurity 46
Isoleucine Impurity 46
CAS No.97550-61-3
Chemical FormulaC6H11NO4
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 47 Hydrochloride structure
47
异亮氨酸杂质47 盐酸盐Isoleucine Impurity 47 Hydrochloride
Isoleucine Impurity 47 Hydrochloride
CAS No.910548-20-8
Chemical FormulaC6H11NO4·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Isoleucine Impurity 10-d3 structure
10-D3
异亮氨酸杂质10-d3Isoleucine Impurity 10-d3
Isoleucine Impurity 10-d3
CAS No.172330-01-7
Chemical FormulaC6H6D3NaO3
Purity>95%询价On request
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

异亮氨酸 —— 研究文献与合成路线Isoleucine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 异亮氨酸 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Isoleucine. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. The influence of dietary leucine above recommendations and fixed ratios to isoleucine and valine on muscle protein synthesis and degradation pathways in broilers
    Zeitz JO, Käding SC, Niewalda IR, et al. · Poultry science · 2019 · 被引 24cited 24
  2. 3-Hydroxyisobutyrate Dehydrogenase Is Involved in Both, Valine and Isoleucine Degradation in Arabidopsis thaliana
    Schertl P, Danne L, Braun HP · Plant physiology · 2017 · 被引 42cited 42
  3. Quantitation and Enantiomeric Ratios of Aroma Compounds Formed by an Ehrlich Degradation of l-Isoleucine in Fermented Foods
    Matheis K, Granvogl M, Schieberle P · Journal of agricultural and food chemistry · 2016 · 被引 41cited 41
  4. Inborn errors of isoleucine degradation: a review
    Korman SH · Molecular genetics and metabolism · 2006 · 被引 54cited 54
  5. The mitochondrial branched-chain aminotransferase (AtBCAT-1) is capable to initiate degradation of leucine, isoleucine and valine in almost all tissues in Arabidopsis thaliana
    Schuster J, Binder S · Plant molecular biology · 2005 · 被引 67cited 67
  6. Role of bkdR, a transcriptional activator of the sigL-dependent isoleucine and valine degradation pathway in Bacillus subtilis
    Debarbouille M, Gardan R, Arnaud M, et al. · Journal of bacteriology · 1999 · 被引 118cited 118

合成与制备工艺专利Synthesis & process patents

  1. Preparation method of L-isoleucine nitrate
    GUOJI ZHANG · 公开号 CN101817757CN101817757 · 2010
  2. MICROORGANISM HAVING ISOLEUCINE-PRODUCING ACTIVITY WITH LOW PRODUCTION OF VALINE AND PROCESS FOR PRODUCING ISOLEUCINE USING THE SAME
    KIM SUOK SU, JANG DONG WOOK, PARK SE JO · 公开号 KR20110061780KR20110061780 · 2011
  3. SOLID SOLUTION OF VALINE, ISOLEUCINE, LEUCINE AND ITS MANUFACTURING METHOD
    KOYAMA MASAKO, KIMURA MOMOKO, TANEGAWA TETSUO · 公开号 US2011257236US2011257236 · 2011
  4. Method for preparing natural 4-hydroxy-isoleucine
    JIANXIN CAO, JIAN FAN, TIANRUI ZHAO, HUILING LIU, et al. · 公开号 CN101544575CN101544575 · 2009
  5. PROCESS FOR PRODUCING (2S,3R,4S)-4-HYDROXY-L-ISOLEUCINE
    SMIRNOV SERGEY VASILIEVICH, SAMSONOVA NATALIA NIKOLAEVNA, KOTLIAROVA VERONIKA ALEKSANDROVNA, RUSHKEVICH NATALIA YURIEVNA, et al. · 公开号 US2010323409US2010323409 · 2010

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

异亮氨酸 杂质谱研究要点Isoleucine — impurity profiling notes

下面这些是拿到 异亮氨酸 的 50 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 50 impurity entries for Isoleucine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances